Emily Schapira Lebow, MD

Radiation Oncology
Accepting new patients
Sees patients age 18 and up
Penn Radiation Oncology Perelman - 2nd Floor
Headshot of Emily Schapira Lebow, MD
Penn Medicine Provider

About me

  • Helene Blum Assistant Professor

My education and training

  • Medical School: Harvard Medical School
  • Residency: Memorial Sloan-Kettering Cancer Center

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Lebow is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Wijetunga NA, Mankuzhy NP, Lebow ES, Boe LA, Pike LRG, Schoenfeld AJ, Shaverdian N, Chaunzwa TL, Jones DR, Chaft JE, Rudin CM, Kris MG, Yu HA, Chang JC, Iyengar P, Gomez DR. Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung Cancer , JCO Precis Oncol: 2026


Friedes C, Berger M, Linkowski L, Hollawell C, Hubbeling H, Alexander D, Kurtz G, Lustig RA, Dorsey JF, Desai AS, Phillips RE, Brem S, Davatzikos C, Nasrallah M, O'Rourke DM, Jackson C, Amankulor NM, Alonso-Basanta M, Mohan S, Bagley SJ, Lebow ES. Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study , J Neurooncol, 177: 2026,125


Messing I, Linkowski L, Riina MD, Berger M, Baron J, Wang X, Kallan M, Hubbeling HG, Lustig RA, Dorsey JF, Kurtz G, Nagda S, Lukens JN, Flowers A, Lee JYK, Amankulor NM, Jackson C, Mohan S, Amaravadi RK, Schuchter LM, Huang AC, Mitchell TC, Alonso-Basanta M, Lebow ES. Outcomes after SRS and ipilimumab plus nivolumab for melanoma brain metastases following prior immune checkpoint inhibitor or targeted therapy , Oncologist, 31: 2026


Mark Baker GammaTile, a novel brachytherapy for neurosurgery, debuts at Penn Medicine , Penn Medicine: 2026


Interview Meningiomas Podcast , Penn Medicine: 2026


Rachel Jaber Chehayeb MD a, Paulina Coutifaris MD a, b, Fawn Whitea, Jonathan Heintz MSc, Saya Jacob MDb, Jennifer Zhang MDb, Lola Fayanju MDb, Emily Lebrow MDb, Neil K. Taunk MDd, Kimberley Lee, MD, Hayley Knollman MDb, Igor Makhlin MDb, Amy S. Clark MD MSCEb, Rachel C. Jankowitz MDb, Anupma Nayak MDb, Susan Domchek MDb, Angela DeMichele MDb, Payal D. Shah, MDb Factors associated with pCR and distant recurrence in patients with early-stage TNBC treated with KN522 , San Antonio Breast Conference: 2025


Ian Messing, Lauren Linkowski, Xingmei Wang, Michael Kallan, Harper G. Hubbeling, Robert A. Lustig, Jay F. Dorsey, Goldie Kurtz, Suneel Nagda, Ahron Flowers, John Y.K. Lee, Nduka M. Amankulor, Christina Jackson, Suyash Mohan, J. Nicholas Lukens, Lynn M. Schuchter, Ravi K. Amaravadi, Alexander C. Haung, Tara Mitchell, Michelle Alonso-Basanta, Emily S. Lebow Outcomes of SRS and Ipilimumab/Nivolumab Among Patients with Melanoma Brain Metastases , Society for Neuro-Oncology (SNO) Annual Meeting, Honolulu, Hawaii : 2025


Jiang C, McWilliams T, Berger M, Lebow ES, Hubbeling H, Azar E, Kolker JD, Nagda SN, Kurtz G, Zou JW, Scheuermann R, Kumar A, Alonso-Basanta M. Periventricular radionecrosis after conventionally fractionated radiation for low grade meningiomas , Radiat Oncol, 20: 2025,175


Friedes C, Berger M, Linkowski L, Hollawell C, Kurtz G, Lustig RA, Dorsey JF, Desai AS, Phillips RE, Nasrallah M, Nabavizadeh A, Brem S, Lee JYK, O’Rourke DM, Amankulor NM, Bagley SJ, Mohan S, Hubbeling H, Alonso-Basanta M, Lebow ES. A Real-World Analysis of Clinical Prognostic Factors Influencing Survival in Patients with High-Grade Glioma (HGG) Receiving Radiotherapy (RT) , American Society of Radiation Oncology (ASTRO) Annual Meeting, San Francisco, California: 2025


Messing I, Riina M, Linkowski L, Wang X, Kallan M, Hubbeling HG, Lustig RA, Dorsey JF, Nagda S, Kolker J, Kurtz G, Amankulor NM, Jackson C, Cajigas I, Lee JYK, DeMichele A, Clark A, Shah P, Alonso-Basanta M, Lebow ES. Survival and CNS Disease Control Among Patients with HER2 Low Versus HER2 High Metastatic Breast Cancer with Brain Metastases Treated with SRS , American Society of Radiation Oncology (ASTRO) Annual Meeting, San Francisco, California: 2025